THE CALANDRA REPORT: Subscribe $91 yearly SAN DIEGO — Inovio Pharmaceuticals (INO in USA), a DNA vaccine developer I sidestepped for four years, is having success with a Middle Eastern virus. INO shares are raging today. Inovio’s J, Joseph Kim, via a persistent biz-dev executive, Bernie Hertel, has been on me, professionally, since 2009. Inovio… Continue Reading
Apple tops $700 billion valuation
A fitting tribute to Pat Quinn
The Rainmaker is back and says GlenTinto merger 'all-but-inevitable'
Another HDI company makes a copper discovery